[1] A. Marcobal and J. L. Sonnenburg, “Human milk oligosaccharide consumption by intestinal microbiota,” Clin. Microbiol. Infect., vol. 18, no. SUPPL. 4, pp. 12–15, 2012, doi: 10.1111/j.1469-0691.2012.03863.x.
[2] M. Derrien, F. Turroni, M. Ventura, and D. van Sinderen, “Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthood,” Trends Microbiol., vol. 30, no. 10, pp. 940–947, 2022, doi: 10.1016/j.tim.2022.04.004.
[3] T. Yatsunenko, F. E. Rey, M. J. Manary, and I. Trehan, “Human gut microbiome viewed across age and geography,” Nature, vol. 486, no. 7402, pp. 222–227, 2012, doi: 10.1038/nature11053.
[4] K. Korpela and W. M. de Vos, “Infant gut microbiota restoration: state of the art,” Gut Microbes, vol. 14, no. 1, pp. 1–14, 2022, doi: 10.1080/19490976.2022.2118811.
[5] C. R. Bakshani and L. I. Crouch, “Human milk oligosaccharides and Bifidobacterium species,” Trends Microbiol., vol. 32, no. 2, pp. 118–119, 2024, doi: 10.1016/j.tim.2023.11.015.
[6] K. Korpela et al., “Selective maternal seeding and environment shape the human gut microbiome,” Genome Res., vol. 28, no. 4, pp. 561–568, 2018, doi: 10.1101/gr.233940.117.
[7] C. Feehily et al., “Detailed mapping of Bifidobacterium strain transmission from mother to infant via a dual culture-based and metagenomic approach,” Nat. Commun., vol. 14, no. 1, pp. 1–14, 2023, doi: 10.1038/s41467-023-38694-0.
[8] C. Milani et al., “The First Microbial Colonizers of the Human Gut : Composition, Activities, and Health Implications of the Infant Gut Microbiota,” Microbiol. Mol. Biol. Rev., vol. 81, no. 4, pp. 1–67, 2017.
[9] K. E. Fujimura, A. R. Sitarik, S. Havstad, and D. L. Lin, “Neonatal gut microbiota associates with childhood multi–sensitized atopy and T–cell differentiation,” Nat Med., vol. 22, no. 10, pp. 1187–1191, 2016, doi: 10.1038/nm.4176.
[10] M. Kalliomäki, P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri, “Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing,” J. Allergy Clin. Immunol., vol. 107, no. 1, pp. 129–134, 2001, doi: 10.1067/mai.2001.111237.
[11] J. Stokholm et al., “Maturation of the gut microbiome and risk of asthma in childhood,” Nat. Commun., vol. 9, no. 1, pp. 1–10, 2018, doi: 10.1038/s41467-017-02573-2.
[12] K. Korpela et al., “Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use,” Microbiome, vol. 5, no. 1, pp. 1–9, 2017, doi: 10.1186/s40168-017-0245-y.
[13] M. Kalliomäki, M. C. Collado, S. Salminen, and E. Isolauri, “Early differences in fecal microbiota composition in children may predict overweight,” Am. J. Clin. Nutr., vol. 87, no. 3, pp. 534–538, 2008, doi: 10.1093/ajcn/87.3.534.
[14] S. Saturio et al., “Role of bifidobacteria on infant health,” Microorganisms, vol. 9, no. 12, pp. 1–29, 2021, doi: 10.3390/microorganisms9122415.
[15] C. Hidalgo-Cantabrana, S. Delgado, L. Ruiz, P. Ruas-Madiedo, B. Sánchez, and A. Margolles, “Bifidobacteria and Their Health-Promoting Effect,” Microbiol. Spectr., vol. 5, no. 3, pp. 1–19, 2017, doi: 10.1128/microbiolspec.BAD-0010-2016.
[16] M. J. Kwak et al., “Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function,” Syst. Appl. Microbiol., vol. 39, no. 7, pp. 429–439, 2016, doi: 10.1016/j.syapm.2016.07.004.
[17] V. K. Batta, S. C. Rao, and S. K. Patole, “Bifidobacterium infantis as a probiotic in preterm infants: a systematic review and meta-analysis,” Pediatr. Res., vol. 94, no. 6, pp. 1887–1905, 2023, doi: 10.1038/s41390-023-02716-w.
[18] M. F. Laursen et al., “Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut,” Nat. Microbiol., vol. 6, no. 11, pp. 1367–1382, 2021, doi: 10.1038/s41564-021-00970-4.
[19] R. Tojo et al., “Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis,” World J. Gastroenterol., vol. 20, no. 41, pp. 15163–15176, 2014, doi: 10.3748/wjg.v20.i41.15163.
[20] B. M. Henrick et al., “Bifidobacteria-mediated immune system imprinting early in life,” Cell, vol. 184, no. 15, pp. 3884-3898.e11, 2021, doi: 10.1016/j.cell.2021.05.030.
[21] K. Vogel et al., “Bifidobacteria shape antimicrobial T-helper cell responses during infancy and adulthood,” Nat. Commun., vol. 14, no. 1, 2023, doi: 10.1038/s41467-023-41630-x.
[22] L. Ruiz, S. Delgado, P. Ruas-Madiedo, B. Sánchez, and A. Margolles, “Bifidobacteria and their molecular communication with the immune system,” Front. Microbiol., vol. 8, no. DEC, pp. 1–9, 2017, doi: 10.3389/fmicb.2017.02345.
[23] N. T. Devika and K. Raman, “Deciphering the metabolic capabilities of Bifidobacteria using genome-scale metabolic models,” Sci. Rep., vol. 9, no. 1, pp. 1–9, 2019, doi: 10.1038/s41598-019-54696-9.
[24] G. A. Stuivenberg, J. P. Burton, P. A. Bron, and G. Reid, “Why Are Bifidobacteria Important for Infants?,” Microorganisms, vol. 10, no. 2, pp. 1–11, 2022, doi: 10.3390/microorganisms10020278.
[25] R. Martin et al., “Early-Life events, including mode of delivery and type of feeding, siblings and gender, shape the developing gut microbiota,” PLoS One, vol. 11, no. 6, pp. 1–30, 2016, doi: 10.1371/journal.pone.0158498.
[26] M. G. Dominguez-Bello et al., “Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns,” Proc. Natl. Acad. Sci. U. S. A., vol. 107, no. 26, pp. 11971–11975, 2010, doi: 10.1073/pnas.1002601107.
[27] G. Biasucci, M. Rubini, S. Riboni, L. Morelli, E. Bessi, and C. Retetangos, “Mode of delivery affects the bacterial community in the newborn gut,” Early Hum. Dev., vol. 86, no. SUPPL. 1, pp. 13–15, 2010, doi: 10.1016/j.earlhumdev.2010.01.004.
[28] F. Fouhy et al., “High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin,” Antimicrob. Agents Chemother., vol. 56, no. 11, pp. 5811–5820, 2012, doi: 10.1128/AAC.00789-12.
[29] A. Uzan-Yulzari et al., “Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization,” Nat. Commun., vol. 12, no. 1, 2021, doi: 10.1038/s41467-020-20495-4.
[30] A. Nogacka et al., “Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates,” Microbiome, vol. 5, no. 1, pp. 1–10, 2017, doi: 10.1186/s40168-017-0313-3.
[31] C. J. Hill et al., “Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort,” Microbiome, vol. 5, no. 1, pp. 1–18, 2017, doi: 10.1186/s40168-016-0213-y.
[32] M. A. C. Zijlmans, K. Korpela, J. M. Riksen-Walraven, W. M. de Vos, and C. de Weerth, “Maternal prenatal stress is associated with the infant intestinal microbiota,” Psychoneuroendocrinology, vol. 53, pp. 233–245, 2015, doi: 10.1016/j.psyneuen.2015.01.006.
[33] M. M. Grönlund et al., “Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease,” Clin. Exp. Allergy, vol. 37, no. 12, pp. 1764–1772, 2007, doi: 10.1111/j.1365-2222.2007.02849.x.
[34] M. R. Olm et al., “Robust variation in infant gut microbiome assembly across a spectrum of lifestyles,” Science, vol. 376, no. 6598, pp. 1220–1223, 2022, doi: 10.1126/science.abj2972.
[35] M. Dinleyici, J. Barbieur, E. C. Dinleyici, and Y. Vandenplas, “Functional effects of human milk oligosaccharides (HMOs),” Gut Microbes, vol. 15, no. 1, 2023, doi: 10.1080/19490976.2023.2186115.
[36] C. Walsh, J. A. Lane, D. Van Sinderen, and R. M. Hickey, “Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health,” J. Funct. Foods, vol. 72, no. January, 2020, doi: https://doi.org/10.1016/j.jff.2020.104074.
[37] G. Puccio et al., “Effects of infant formula with human milk oligosaccharides on growth and morbidity: A randomized multicenter trial,” J. Pediatr. Gastroenterol. Nutr., vol. 64, no. 4, pp. 624–631, 2017, doi: 10.1097/MPG.0000000000001520.
[38] K. C. Goehring, B. J. Marriage, J. S. Oliver, J. A. Wilder, E. G. Barrett, and R. H. Buck, “Similar to those who are breastfed, infants fed a formula containing 2’-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial,” J. Nutr., vol. 146, no. 12, pp. 2559–2566, 2016, doi: 10.3945/jn.116.236919.
[39] D. McDonald et al., “American Gut: an Open Platform for Citizen Science Microbiome Research,” mSystems, vol. 3, no. 3, pp. 1–28, 2018, [Online]. Available: http://humanfoodproject.com/
[40] H. C. Wastyk et al., “Gut-microbiota-targeted diets modulate human immune status,” Cell, vol. 184, no. 16, pp. 4137-4153.e14, 2021, doi: 10.1016/j.cell.2021.06.019.
[41] T. Fernandes, “Fermented Food Guidelines for Children,” J. Pediatr. Pediatr. Med., vol. 2, no. 1, pp. 1–4, 2018, doi: 10.29245/2578-2940/2018/1.1111.
[42] P. Ferretti et al., “Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome,” Cell Host Microbe, vol. 24, no. 1, pp. 133-145.e5, 2018, doi: 10.1016/j.chom.2018.06.005.